STAAR Ovarian Cancer

📍 Chicago, United States🗓 Founded 2020👥 4 employees💰 Last funded Jul 2024
STAAR exists to raise critical funds for life-saving research for those with low-grade ovarian cancer. STAAR was co-founded by three low-grade ovarian cancer thrivers in early 2020. The foundation exists to fund research for better treatment options for low-grade serous carcinoma, a rare (less than 10% of ovarian cancer cases) and extremely underfunded subtype. Low-grade serous carcinoma is often labeled as a "tricky opponent" by clinicians because it acts differently than more common subtypes - it grows slower and is often chemo-resistant, leaving fewer treatment options. The average age of diagnosis is 18 years younger than ovarian cancer overall, meaning that many diagnosed are young moms or never got a chance to have children. Research dedicated to low-grade ovarian cancer is desperately needed to give women a chance at longer lives. ​For more information on low-grade serous carcinoma, please visit our friends at Cure Our Ovarian Cancer, the leading global charity dedicated to low-grade research.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in STAAR Ovarian Cancer?
STAAR Ovarian Cancer has 1 investors on record on gritt.io, 1 mid-stage.
When did STAAR Ovarian Cancer last raise funding?
The most recent investment in STAAR Ovarian Cancer recorded on gritt.io was in July 2024.
When was STAAR Ovarian Cancer founded?
STAAR Ovarian Cancer was founded in 2020.
What industry is STAAR Ovarian Cancer in?
STAAR Ovarian Cancer operates in Non-profit Organizations. Find similar Non-profit Organizations investors on gritt.io.
Where is STAAR Ovarian Cancer based?
STAAR Ovarian Cancer is headquartered in Chicago, United States.